Universitätsklinikum Heidelberg

Hospital


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000103284908

ROR: https://ror.org/013czdx64

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial (2019) Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, et al. Journal article Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with 18F (2019) Daum S, Toms J, Reshetnikov V, Özkan H, Hampel F, Maschauer S, Hakimioun AH, et al. Journal article, Original article Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer (2019) Von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, et al. Journal article Spectrum and functional validation of PSMB5 mutations in multiple myeloma (2019) Barrio S, Stuehmer T, Da-Via M, Barrio-Garcia C, Lehners N, Besse A, Cuenca I, et al. Journal article A step towards international prospective trials in carbon ion radiotherapy: Investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma (2019) Vogin G, Wambersie A, Koto M, Ohno T, Uhl M, Fossati P, Balosso J Journal article Translational highlights in breast cancer research and treatment: recent developments with clinical impact (2019) Fasching P, Schneeweiss A, Kolberg HC, Ettl J, Fehm TN, Overkamp F, Lueftner D Journal article, Review article Circulating tumor cells in metastatic breast cancer: clinical relevance and biological potential (2019) Arkadius P, Marie T, Fabienne S, Thomas WPF, Brigitte R, Andreas H, Fasching P, et al. Journal article, Review article The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial (2019) Hadji P, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, et al. Journal article Gelatin coating increases in vivo bone formation capacity of three-dimensional 45S5 bioactive glass-based crystalline scaffolds (2019) Westhauser F, Senger AS, Obert D, Ciraldo F, Schuhladen K, Schmidmaier G, Moghaddam A, Boccaccini AR Journal article Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation (2019) Pfeuffer S, Schmidt R, Straeten FA, Pul R, Kleinschnitz C, Wieshuber M, Lee DH, et al. Journal article